- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
MPX Opens New Medical Marijuana Dispensary in Phoenix
MPX Bioceutical Corporation announced the opening of its most recent “Health for Life” medical marijuana dispensary in Phoenix.
MPX Bioceutical Corporation (CSE:MPX; OTC:MPXEF) announced the opening of its most recent “Health for Life” medical marijuana dispensary in Phoenix.
As quoted in the press release:
This brings the number of dispensaries under MPX management in Arizona’s Sun Valley to four. The Crimson dispensary will meet the needs of patients in this comparatively underserviced southeast quadrant of the region by making available the full spectrum of MPX concentrates, an extensive variety of cannabis flower, and a broad selection of [third] party, processed cannabis-infused edibles.
Beth Stavola, MPX’s COO and President of U.S. Operations, and the principal architect of the Company’s continued Arizona expansion says, “The addition of yet another dispensary in the Phoenix region and our launch of a significantly-expanded production capacity for MPX concentrates, are both indicative of our commitment to patients in this marketplace. As well, our growth in Arizona reflects our continued capital investment and employment creation in the state. We now employ over 150 staff at our various facilities in the Phoenix Metropolitan area, all of which receive extensive training and enjoy above-average salaries and benefits.”
Click here to read the full press release.
Source: globenewswire.com
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.